Capital Expenditures for Insulet (PODD)
According to Insulet's latest reported financial statements, the company's current capital expenditures (TTM) is $191.60M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
PODD
Currently viewingCapital ExpendituresSwitch metric
Latest period
$191.60M
YoY change
+53.4%
5Y CAGR
+2.8%
Peak year (2025)
$191.60M
Cumulative capital expenditures
$1.37B
CapEx history chart for Insulet (PODD) from 2004 to 2025
CapEx history table for Insulet (PODD) from 2004 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $191.60M | +53.4% | ||
| 2024 | $124.90M | +65.2% | ||
| 2023 | $75.60M | -51.9% | ||
| 2022 | $157.30M | +28.2% | ||
| 2021 | $122.70M | -26.3% | ||
| 2020 | $166.50M | -2.6% | ||
| 2019 | $170.90M | +5.3% | ||
| 2018 | $162.35M | +110.2% | ||
| 2017 | $77.23M | +249.2% | ||
| 2016 | $22.11M | +108.5% | ||
| 2015 | $10.61M | -7.6% | ||
| 2014 | $11.49M | +57.2% | ||
| 2013 | $7.31M | -33.5% | ||
| 2012 | $10.99M | -1.1% | ||
| 2011 | $11.11M | +69.7% | ||
| 2010 | $6.55M | +108.6% | ||
| 2009 | $3.14M | -68.7% | ||
| 2008 | $10.05M | -0.4% | ||
| 2007 | $10.09M | -23.2% | ||
| 2006 | $13.14M | +140.1% | ||
| 2005 | $5.47M | +102.1% | ||
| 2004 | $2.71M | — |
CapEx values are taken from Insulet's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Insulet (PODD) capital expenditures totalled $191.60M – surged 53.4% year-over-year.
Through 2020–2025 (5 years), Insulet capital expenditures delivered a +2.8% annualised rate; sustaining 2 straight years of year-over-year growth.
2025 marks the peak capital expenditures at $191.60M, with the historical low of $2.71M recorded in 2004.
Insulet (PODD) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Insulet Capital Expenditures by Year
Insulet Capital Expenditures 2025: $191.60M
Insulet capital expenditures in 2025 was $191.60M, surged 53.4% from 2024. This figure represents the highest annual value in the available history.
Insulet Capital Expenditures 2024: $124.90M
Insulet capital expenditures in 2024 was $124.90M, surged 65.2% from 2023.
Insulet Capital Expenditures 2023: $75.60M
Insulet capital expenditures in 2023 was $75.60M, plunged 51.9% below 2022.
Insulet Capital Expenditures 2022: $157.30M
Insulet capital expenditures in 2022 was $157.30M, grew 28.2% from 2021.
Insulet Capital Expenditures 2021: $122.70M
Insulet capital expenditures in 2021 was $122.70M.
See more financial history for Insulet (PODD).
Sector peers — CapEx
Companies in the same sector as Insulet, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Insulet's capital expenditures?
- Latest reported capital expenditures for Insulet (PODD) is $191.60M (period ending December 31, 2025).
How has Insulet capital expenditures changed year-over-year?
- Insulet (PODD) capital expenditures changed +53.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Insulet capital expenditures?
- Insulet (PODD) capital expenditures compound annual growth rate is +2.8% over the most recent 5 years available.
When did Insulet capital expenditures hit its highest annual value?
- Insulet capital expenditures reached its highest annual value of $191.60M in 2025.
What was Insulet capital expenditures in 2024?
- Insulet (PODD) capital expenditures in 2024 was $124.90M.
What was Insulet capital expenditures in 2025?
- Insulet (PODD) capital expenditures in 2025 was $191.60M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
PODD Overview
Company profile, financial tools, and key metrics
PODD Revenue Counter
Earns $85.88 every second. See per minute, hour, and day.
PODD Earnings Counter
Earns $7.84 per second net profit. See per minute, hour, and day.
PODD Economic Scale
Exceeds St. Lucia's GDP. Compare with world economies.
PODD What If Invested
What if you had invested $1,000? See historical returns from any date.
PODD How It Makes Money
Discover visual breakdown of $2.71B in revenue — where it comes from and where it goes.
PODD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PODD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PODD Daily Price Character
Explosive · 51.5% historical win rate (green days). Streaks & record days.
PODD Buybacks
0.30% TTM buyback yield. Shareholder yield & SBC comparison.